CTOs on the Move


 
Empi, Inc is a medical device company focused on products used for pain management, orthopedic rehabilitation and physical therapy. The Company develops, manufactures, markets and distributes a diverse range of non-invasive medical devices and related
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.empi.com
  • 599 Cardigan Rd
    Saint Paul, MN USA 55126
  • Phone: 651.415.9000

Executives

Name Title Contact Details

Similar Companies

Valley Health Care System

Valley Health Care System is a Columbus, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prison Health Services

Prison Health Services is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Prncipals Group

Healthcare Prncipals Group LLC is a Beaufort, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Volition

Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. Volition`s research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.

Nymox

NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.